BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
最近の投稿
- 1
Lahav 433 head Asst.-Ch. Meni Benjamin named as police officer investigated for breach of trust - 2Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- 3My daughter is in the #1 movie in the country. She still has to finish her math homework.
- 4'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
- 5A definitive Manual for Web based Mastering and Expertise Improvement
- Giant ‘toothed’ birds flew over Antarctica 40 million to 50 million years ago
- 5 Movies That Leaving an Imprint with Inventive Innovation
- 5 Superstar Couples That Motivate Relationship Objectives
- Worldwide Objections Ideal For A Golf Outing
- Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Colleges say foreign students feel 'unwelcome' in the U.S. amid big drop in international enrollment, new survey finds
- Kids with smartphones by age 12 are at higher risk of health issues, study finds
- Figure out How to Pick the Right Dental specialist for Your Dental Inserts
